Log in to save to my catalogue

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 pati...

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 pati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2488019080

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

About this item

Full title

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2021-02, Vol.6 (1), p.58-9, Article 58

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-mesenchymal stem cells (UC-MSCs) to treat severe COVID-19 patients with lung damage, based on our phase 1 data. In this randomized, double-blind, and placebo-controlled trial, we recruited 10...

Alternative Titles

Full title

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2488019080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2488019080

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-021-00488-5

How to access this item